Clinical Trials Logo

Ulcer, Leg clinical trials

View clinical trials related to Ulcer, Leg.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT05890703 Recruiting - Ulcer, Leg Clinical Trials

Painless Sharp Wound Debridement With Lidocaine-23%-Tetra-caine-7% Gel Versus EMLA 5% Cream

LIDOTETRA
Start date: June 1, 2023
Phase: Phase 2
Study type: Interventional

In a single-blind, crossover, randomized, controlled trial with 40 participants we aim to demonstrate superior anaesthetic efficacy of lidocaine-23%-tetracaine-7% (IMP2) gel over EMLA 5% cream (IMP1) at comparable safety in sharp wound debridement of chronic leg ulcers. This is a monocentric investigator initiated trial conducted in the University Hospital Zurich. In this longitudinal trial, participants receive a sequence of different treatments (treatments on different days) and therefore are randomly assigned to one of two treatment sequences. One-half of participants will first receive IMP1 (first treatment visit, randomized) and then IMP2 (second treatment visit, crossover); the other half of participants the reverse sequence (first treatment visit: IMP2, second treatment visit: IMP1). Primary Objective: We want to show that IMP 2 (lidocaine-23%-tetracaine-7% gel) is more effective in pain reduction than IMP 1 (EMLA® 5% cream) in sharp wound debridement.

NCT ID: NCT04210089 Recruiting - Diabetes Mellitus Clinical Trials

Total Contact Soft Cast in Diabetic Foot Ulcers

Start date: October 13, 2020
Phase: N/A
Study type: Interventional

To determine the effectiveness, compliance, patient tolerance, ease of use and safety of total contact soft cast in diabetic foot ulcers.